Neural basis of psychosis-related behaviour in the infection model of schizophrenia

Behavioural Brain Research

Volumn 204, Issue 2, 2009, Pages 322-334

  Meyer, Urs ^a,b   Feldon, Joram ^a  

^a ETH ZURICH   (Switzerland)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Behaviour; Cognition; Dopamine; GABA; Glutamate; Hippocampus; Neurodevelopment; Prefrontal cortex; Schizophrenia; Serotonin; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE RECEPTOR; GLUTAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PSYCHOSTIMULANT AGENT; SEROTONIN;

ARTICLE; BRAIN DEVELOPMENT; DOPAMINERGIC SYSTEM; GLIOSIS; HIPPOCAMPUS; HUMAN; INFLAMMATION; INTRAUTERINE INFECTION; LATENT INHIBITION; LIMBIC SYSTEM; MEMORY DISORDER; NEUROPATHOLOGY; NONHUMAN; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; STATE DEPENDENT LEARNING; WORKING MEMORY;

ANIMALS; AVOIDANCE LEARNING; BRAIN; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MICE; NEURONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOTIC DISORDERS; RATS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSORY GATING; SEROTONIN;

EID: 69249248178     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.12.022     Document Type: Article

References (200)

1. Abi-Dargham A., Laruelle M., Aghajanian G.K., Charney D., and Krystal J. The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatry Clin Neurosci 9 (1997) 1-17
2. Abi-Dargham A., Mawlawi O., Lombardo I., Gil R., Martinez D., Huang Y., et al. Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22 (2002) 3708-3719
3. Abi-Dargham A., and Moore H. Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9 (2003) 404-416
4. Abi-Dargham A. Alterations of serotonin transmission in schizophrenia. Int Rev Neurobiol 78 (2007) 133-164
5. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney Jr. W.E., et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52 (1995) 258-266
6. Alheid G.F., and Heimer L. Theories of basal forebrain organization and the "emotional motor system". Prog Brain Res 107 (1996) 461-484
7. Arguello P.A., and Gogos J.A. Modeling madness in mice: one piece at a time. Neuron 52 (2006) 179-196
8. Aronsson F., Lannebo C., Paucar M., Brask J., Kristensson K., and Karlsson H. Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy. J Neurovirol 8 (2002) 353-357
9. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., and Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 11 (2006) 47-55
10. Babulas V., Factor-Litvak P., Goetz R., Schaefer C.A., and Brown A.S. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry 163 (2006) 927-929
11. Bacopoulos N.G., and Bhatnagar R.K. Correlation between tyrosine hydroxylase activity and catecholamine concentration or turnover in brain regions. J Neurochem 29 (1977) 639-643
12. Baddeley A., and Hitch G.J. Working memory. In: Brower G. (Ed). Recent advances in learning and motivation (1974), Academic Press, New York, USA
13. Baddeley A. Working memory: looking back and looking forward. Nat Rev Neurosci 4 (2003) 829-839
14. Bannerman D.M., Niewoehner B., Lyon L., Romberg C., Schmitt W.B., Taylor A., et al. NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory. J Neurosci 28 (2008) 3623-3630
15. Bannerman D.M., Yee B.K., Good M.A., Heupel M.J., Iversen S.D., and Rawlins J.N. Double dissociation of function within the hippocampus: a comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions. Behav Neurosci 113 (1999) 1170-1188
16. Bannon M.J., and Roth R.H. Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 35 (1983) 53-68
17. Bast T., and Feldon J. Hippocampal modulation of sensorimotor processes. Prog Neurobiol 70 (2003) 319-345
18. Bast T., Zhang W.N., and Feldon J. Hyperactivity, decreased startle reactivity, and disrupted prepulse inhibition following disinhibition of the rat ventral hippocampus by the GABA(A) receptor antagonist picrotoxin. Psychopharmacology 156 (2001) 225-233
19. Bast T., Zhang W.N., Heidbreder C., and Feldon J. Hyperactivity and disruption of prepulse inhibition induced by N-methyl-d-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine. Neuroscience 103 (2001) 325-335
20. Beasley C.L., and Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res 24 (1997) 349-355
21. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., and Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48 (1991) 996-1001
22. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12 (1992) 924-929
23. Benes F.M., Vincent S.L., Marie A., and Khan Y. Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75 (1996) 1021-1031
24. Benveniste E.N. Cytokine actions in the central nervous system. Cytokine Growth Factor Rev 9 (1998) 259-275
25. Boksa P. Maternal infection during pregnancy and schizophrenia. J Psychiatry Neurosci 33 (2008) 183-185
26. Borrell J., Vela J.M., Arévalo-Martin A., Molina-Holgado E., and Guaza C. Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26 (2002) 204-215
27. Brady A.M., and O'Donnell P. Dopaminergic modulation of prefrontal cortical input to nucleus accumbens neurons in vivo. J Neurosci 24 (2004) 1040-1049
28. Broersen L.M., Feldon J., and Weiner I. Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience 94 (1999) 39-46
29. Broersen L.M. Attentional processes and learning and memory in rats: the prefrontal cortex and hippocampus compared. Prog. Brain Res 126 (2000) 79-94
30. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 61 (2004) 774-780
31. Brown A.S., Cohen P., Harkavy-Friedman J., Babulas V., Malaspina D., Gorman J.M., et al. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry 49 (2001) 473-486
32. Brown A.S., Schaefer C.A., Quesenberry Jr. C.P., Liu L., Babulas V.P., and Susser E.S. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 162 (2005) 767-773
33. Brown A.S., and Susser E.S. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 8 (2002) 51-57
34. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 32 (2006) 200-202
35. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., and Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 58 (2001) 1032-1037
36. Cai Z., Pan Z.L., Pang Y., Evans O.B., and Rhodes P.G. Cytokine induction in fetal rat brains and brain injury in neonatal rats after maternal lipopolysaccharide administration. Pediatr Res 47 (2000) 64-72
37. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., and Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41 (2001) 237-260
38. Carlsson A. Does dopamine play a role in schizophrenia?. Psychol Med 7 (1977) 583-597
39. Carlsson M., and Carlsson A. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75 (1989) 221-226
40. Chartoff E.H., Heusner C.L., and Palmiter R.D. Dopamine is not required for the hyperlocomotor response to NMDA receptor antagonists. Neuropsychopharmacology 30 (2005) 1324-1333
41. Creese I., and Iversen S.D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83 (1975) 419-436
42. Csernansky J.G., Murphy G.M., and Faustman W.O. Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biol Psychiatry 30 (1991) 383-400
43. Cull-Candy S., Brickley S., and Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11 (2001) 327-335
44. Davis S., Butcher S.P., and Morris R.G. The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci 12 (1992) 21-34
45. de Jong I.E., and van den Buuse M. SCH 23390 in the prefrontal cortex enhances the effect of apomorphine on prepulse inhibition of rats. Neuropharmacology 51 (2006) 438-446
46. Dean B., Hussain T., Hayes W., Scarr E., Kitsoulis S., Hill C., et al. Changes in serotonin2A and GABA(A) receptors in schizophrenia: studies on the human dorsolateral prefrontal cortex. J Neurochem 72 (1999) 1593-1599
47. Dean B., Pavey G., Scarr E., Goeringer K., and Copolov D.L. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia. Life Sci 74 (2004) 3115-3131
48. Dean K., and Murray R.M. Environmental risk factors for psychosis. Dialogues Clin Neurosci 7 (2005) 69-80
49. Del Arco A., and Mora F. Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex. Pharmacol Biochem Behav 90 (2008) 226-235
50. Deutch A.Y. The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm Suppl 36 (1992) 61-89
51. Di Forti M., Lappin J.M., and Murray R.M. Risk factors for schizophrenia-all roads lead to dopamine. Eur Neuropsychopharmacol 17 (2007) S101-107
52. Ellenbroek B.A., Budde S., and Cools A.R. Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 75 (1996) 535-542
53. Eyles D.W., McGrath J.J., and Reynolds G.P. Neuronal calcium-binding proteins and schizophrenia. Schizophr Res 57 (2002) 27-34
54. Farber N.B. The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci 1003 (2003) 119-130
55. Fatemi S.H., Araghi-Niknam M., Laurence J.A., Stary J.M., Sidwell R.W., and Lee S. Glial fibrillary acidic protein and glutamic acid decarboxylase 65 and 67 kDa proteins are increased in brains of neonatal BALB/c mice following viral infection in utero. Schizophr Res 69 (2004) 121-123
56. Fatemi S.H., Cuadra A.E., El-Fakahany E.E., Sidwell R.W., and Thuras P. Prenatal viral infection causes alterations in nNOS expression in developing mouse brains. Neuroreport 11 (2000) 1493-1496
57. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 22 (2002) 25-33
58. Fatemi S.H., Emamian E.S., Kist D., Sidwell R.W., Nakajima K., Akhter P., et al. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 4 (1999) 145-154
59. Fatemi S.H., Emamian E.S., Sidwell R.W., Kist D.A., Stary J.M., Earle J.A., et al. Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice. Mol Psychiatry 7 (2002) 633-640
60. Fatemi S.H., Reutiman T.J., Folsom T.D., Huang H., Oishi K., Mori S., et al. Maternal infection leads to abnormal gene regulation and brain atrophy in mouse offspring: implications for genesis of neurodevelopmental disorders. Schizophr Res 99 (2008) 56-70
61. Fatemi S.H., Sidwell R., Akhter P., Sedgewick J., Thuras P., Bailey K., et al. Human influenza viral infection in utero increases nNOS expression in hippocampi of neonatal mice. Synapse 29 (1998) 84-88
62. Fatemi S.H. Neuropsychiatric disorders and infection (2005), Martin Dunitz-Taylor & Francis Group, London, UK
63. Fatemi S.H. Reelin glycoprotein in autism and schizophrenia. Int Rev Neurobiol 71 (2005) 179-187
64. Fatemi S.H. Reelin glycoprotein: structure, biology and roles in health and disease. Mol Psychiatry 10 (2005) 251-257
65. Fortier M.E., Joober R., Luheshi G.N., and Boksa P. Maternal exposure to bacterial endotoxin during pregnancy enhances amphetamine-induced locomotion and startle responses in adult rat offspring. J Psychiatr Res 38 (2004) 335-345
66. Fortier M.E., Luheshi G.N., and Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 181 (2007) 270-277
67. French E.D., Mura A., and Wang T. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists. Synapse 13 (1993) 108-116
68. Geyer M.A., and Vollenweider F.X. Serotonin research: contributions to understanding psychoses. Trends Pharmacol Sci 29 (2008) 445-453
69. Gilmore J.H., and Jarskog L.F. Exposure to infection and brain development: cytokines in the pathogenesis of schizophrenia. Schizophr Res 24 (1997) 365-367
70. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 158 (2001) 1367-1377
71. Golan H.M., Lev V., Hallak M., Sorokin Y., and Huleihel M. Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 48 (2005) 903-917
72. Goldman-Rakic P.S. Prefrontal cortical dysfunction in working memory: the relevance of working memory. In: Caroll B.J., and Barett J.E. (Eds). Psychopathology in the brain (1991), Raven, New York, USA
73. Gray J.A., Feldon J., Rawlins J.N.P., Hemsley D.R., and Smith A.D. The neuropsychology of schizophrenia. Behav Brain Sci 14 (1991) 1-84
74. Groenewegen H.J., Vermeulen-Van der Zee E., te Kortschot A., and Witter M.P. Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. Neuroscience 23 (1987) 103-120
75. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 57 (2000) 1061-1069
76. Guillin O., Abi-Dargham A., and Laruelle M. Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78 (2007) 1-39
77. Hanada S., Mita T., Nishino N., and Tanaka C. [3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sci 40 (1987) 259-266
78. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10 (2005) 40-68
79. Harte M., and O'Connor W.T. Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat. Brain Res 13 1017 (2004) 120-129
80. Hashimoto T., Arion D., Unger T., Maldonado-Avilés J.G., Morris H.M., Volk D.W., et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 13 (2008) 147-161
81. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23 (2003) 6315-6326
82. Heidbreder C., and Feldon J. Amphetamine-induced neurochemical and locomotor responses are expressed differentially across the anteroposterior axis of the core and shell subterritories of the nucleus accumbens. Synapse 29 (1998) 310-322
83. Herlenius E., and Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp Neurol 190 (2004) S8-21
84. Holstege G. Descending motor pathways and the spinal motor system: limbic and non-limbic components. Prog. Brain Res 87 (1991) 307-421
85. Hutton L.C., Castillo-Melendez M., Smythe G.A., and Walker D.W. Microglial activation, macrophage infiltration, and evidence of cell death in the fetal brain after uteroplacental administration of lipopolysaccharide in sheep in late gestation. Am J Obstet Gynecol 198 (2008) 117.e1-117.e11
86. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 95 (1998) 15718-15723
87. Jarskog L.F., Miyamoto S., and Lieberman J.A. Schizophrenia: new pathological insights and therapies. Annu Rev Med 58 (2007) 49-61
88. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148 (1991) 1301-1308
89. Joel D., and Weiner I. The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96 (2000) 451-474
90. Koch M., and Schnitzler H.U. The acoustic startle response in rats-circuits mediating evocation, inhibition and potentiation. Behav Brain Res 89 (1997) 35-49
91. Koch M. The neurobiology of startle. Prog Neurobiol 59 (1999) 107-128
92. Köhr G. NMDA receptor function: subunit composition versus spatial distribution. Cell Tissue Res 326 (2006) 439-446
93. Kretschmer B.D. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors. J Neurochem 73 (1999) 839-848
94. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51 (1994) 199-214
95. Lacroix L., Broersen L.M., Feldon J., and Weiner I. Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity. Behav Brain Res 107 (2000) 111-121
96. Lacroix L., Broersen L.M., Weiner I., and Feldon J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience 84 (1998) 431-442
97. Lahti A.C., Koffel B., LaPorte D., and Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13 (1995) 9-19
98. Laruelle M., Abi-Dargham A., Gil R., Kegeles L., and Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46 (1999) 56-72
99. Laruelle M., Abi-Dargham A., van Dyck C.H., Gil R., D'Souza C.D., Erdos J., et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93 (1996) 9235-9240
100. Laruelle M., Kegeles L.S., and Abi-Dargham A. Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann NY Acad Sci 1003 (2003) 138-158
101. Legault M., and Wise R.A. Injections of N-methyl-d-aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens. Synapse 31 (1999) 241-249
102. Lewis D.A., Cruz D.A., Melchitzky D.S., and Pierri J.N. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am J Psychiatry 158 (2001) 1411-1422
103. Lewis D.A., Hashimoto T., and Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6 (2005) 312-324
104. Lieberman J.A., Kane J.M., and Alvir J. Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology 91 (1987) 415-433
105. Limosin F., Rouillon F., Payan C., Cohen J.M., and Strub N. Prenatal exposure to influenza as a risk factor for adult schizophrenia. Acta Psychiatr Scand 107 (2003) 331-335
106. Lipska B.K., and Weinberger D.R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23 (2000) 223-239
107. Luján R., Shigemoto R., and López-Bendito G. Glutamate and GABA receptor signalling in the developing brain. Neuroscience 130 (2005) 567-580
108. Mackay A.V., Iversen L.L., Rossor M., Spokes E., Bird E., Arregui A., et al. Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 39 (1982) 991-997
109. Makinodan M., Tatsumi K., Manabe T., Yamauchi T., Makinodan E., Matsuyoshi H., et al. Maternal immune activation in mice delays myelination and axonal development in the hippocampus of the offspring. J Neurosci Res 86 (2008) 2190-2200
110. Mathé J.M., Nomikos G.G., Hildebrand B.E., Hertel P., and Svensson T.H. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens. Eur J Pharmacol 309 (1996) 1-11
111. McDonald C., and Murray R.M. Early and late environmental factors for schizophrenia. Brain Res Rev 31 (2000) 130-137
112. Mednick S.A., Machon R.A., Huttunen M.O., and Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 45 (1988) 189-192
113. Meltzer H.Y., and Stahl S.M. The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2 (1976) 19-76
114. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun 20 (2006) 378-388
115. Meyer U., Feldon J., Schedlowski M., and Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 29 (2005) 913-947
116. Meyer U, Feldon J, Yee BK. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull; in press (Epub ahead of print [PMID: 18408229]).
117. Meyer U., Murray P.J., Urwyler A., Yee B.K., Schedlowski M., and Feldon J. Adult behavioral and pharmacological dysfunctions following disruption of the fetal brain balance between pro-inflammatory and IL-10-mediated anti-inflammatory signaling. Mol Psychiatry 13 (2008) 208-221
118. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 26 (2006) 4752-4762
119. Meyer U., Nyffeler M., Schwendener S., Knuesel I., Yee B.K., and Feldon J. Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology 33 (2008) 441-456
120. Meyer U., Nyffeler M., Yee B.K., Knuesel I., and Feldon J. Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun 22 (2008) 469-486
121. Meyer U., Schwendener S., Feldon J., and Yee B.K. Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res 173 (2006) 243-257
122. Meyer U., Yee B.K., and Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist 13 (2007) 241-256
123. Mogenson G.J., Jones D.L., and Yim C.Y. From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol 14 (1980) 69-97
124. Mogenson G.J., and Yang C.R. The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. Adv Exp Med Biol 295 (1991) 267-290
125. Möhler H., Rudolph U., Boison D., Singer P., Feldon J., and Yee B.K. Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1. Pharmacol Biochem Behav 90 (2008) 58-64
126. Montaron M.F., Deniau J.M., Menetrey A., Glowinski J., and Thierry A.M. Prefrontal cortex inputs of the nucleus accumbens-nigro-thalamic circuit. Neuroscience 71 (1996) 371-382
127. Morris R.G., Anderson E., Lynch G.S., and Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate receptor antagonist, AP5. Nature 319 (1986) 774-776
128. Mortensen P.B., Nørgaard-Pedersen B., Waltoft B.L., Sørensen T.L., Hougaard D., Torrey E.F., et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 61 (2007) 688-693
129. Moser E., Moser M.B., and Andersen P. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions. J Neurosci 13 (1993) 3916-3925
130. Moser M.B., Moser E.I., Forrest E., Andersen P., and Morris R.G. Spatial learning with a minislab in the dorsal hippocampus. Proc Natl Acad Sci USA 92 (1995) 9697-9701
131. Müller N., and Schwarz M. Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10 (2006) 131-148
132. Murase S., Mathé J.M., Grenhoff J., and Svensson T.H. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. J Neural Transm Gen Sect 91 (1993) 13-25
133. Murray R.M., O'Callaghan E., Castle D.J., and Lewis S.W. A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 18 (1992) 319-332
134. Nakazawa K., Sun L.D., Quirk M.C., Rondi-Reig L., Wilson M.A., and Tonegawa S. Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience. Neuron 38 (2003) 305-315
135. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol 67 (2002) 53-83
136. Niewoehner B., Single F.N., Hvalby Ø., Jensen V., Meyer zum Alten Borgloh S., Seeburg P.H., et al. Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus. Eur J Neurosci 25 (2007) 837-846
137. Nitsos I., Rees S.M., Duncan J., Kramer B.W., Harding R., Newnham J.P., et al. Chronic exposure to intra-amniotic lipopolysaccharide affects the ovine fetal brain. J Soc Gynecol Investig 13 (2006) 239-247
138. A receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 143 (2006) 51-62
139. Okubo Y., Suhara T., Sudo Y., and Toru M. Possible role of dopamine D1 receptors in schizophrenia. Mol Psychiatry 2 (1997) 291-292
140. Okubo Y., Suhara T., Suzuki K., Kobayashi K., Inoue O., Terasaki O., et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385 (1997) 634-636
141. Olton D.S., and Papas B.C. Spatial memory and hippocampal function. Neuropsychologia 17 (1979) 669-682
142. Opler M.G., and Susser E.S. Fetal environment and schizophrenia. Environ Health Perspect 113 (2005) 1239-1242
143. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., and Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 59 (2006) 546-554
144. Patterson P.H. Neuroscience. Maternal effects on schizophrenia risk. Science 318 (2007) 576-577
145. Peleg-Raibstein D., and Feldon J. Effects of dorsal and ventral hippocampal NMDA stimulation on nucleus accumbens core and shell dopamine release. Neuropharmacology 51 (2006) 947-957
146. Pijnenburg A.J., Honig W.M., Van der Heyden J.A., and Van Rossum J.M. Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35 (1976) 45-58
147. Pothuizen H.H., Zhang W.N., Jongen-Rêlo A.L., Feldon J., and Yee B.K. Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur J Neurosci 19 (2004) 705-712
148. A receptors mediate phasic and tonic forms of inhibition in hippocampal pyramidal neurons. J Neurophysiol 96 (2006) 846-857
149. Rapoport J.L., Addington A.M., Frangou S., and Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 10 (2005) 434-449
150. Reynolds G.P., Reynolds L.M., Riederer P., Jellinger K., and Gabriel E. Dopamine receptors and schizophrenia: drug effect or illness. Lancet 2 (1980) 1251
151. Reynolds G.P., Zhang Z.J., and Beasley C.L. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity. Brain Res Bull 55 (2001) 579-584
152. Robertson G.S., and Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46 (1992) 315-328
153. Romero E., Ali C., Molina-Holgado E., Castellano B., Guaza C., and Borrell J. Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics. Neuropsychopharmacology 32 (2007) 1791-1804
154. Romero E, Guaza C, Castellano B, Borrell J. Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia. Mol Psychiatry; in press (Epub ahead of print [PMID: 18414405]).
155. Ross C.A., Margolis R.L., Reading S.A., Pletnikov M., and Coyle J.T. Neurobiology of schizophrenia. Neuron 52 (2006) 139-153
156. Rothblat D.S., and Schneider J.S. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum. Neurosci Lett 228 (1997) 119-122
157. Roumier A., Pascual O., Béchade C., Wakselman S., Poncer J.C., Réal E., et al. Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function. PLoS ONE 3 (2008) e2595
158. Samuelsson A.M., Jennische E., Hansson H.A., and Holmäng A. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am J Physiol Regul Integr Comp Physiol 290 (2006) R1345-R1356
159. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1 (1987) 133-152
160. Shi L., Fatemi S.H., Sidwell R.W., and Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23 (2003) 297-302
161. Shoemaker J.M., Saint Marie R.L., Bongiovanni M.J., Neary A.C., Tochen L.S., and Swerdlow N.R. Prefrontal D1 and ventral hippocampal N-methyl-d-aspartate regulation of startle gating in rats. Neuroscience 135 (2005) 385-394
162. Smith S.E., Li J., Garbett K., Mirnics K., and Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 27 (2007) 10695-10702
163. Snyder S.H. The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. Am J Psychiatry 133 (1976) 197-202
164. Somogyi P., and Klausberger T. Defined types of cortical interneurone structure space and spike timing in the hippocampus. J Physiol 562 (2005) 9-26
165. Spencer K.M., Nestor P.G., Perlmutter R., Niznikiewicz M.A., Klump M.C., Frumin M., et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci USA 101 (2004) 17288-17293
166. Stöber G., Franzek E., Beckmann H., and Schmidtke A. Exposure to prenatal infections, genetics and the risk of systematic and periodic catatonia. J Neural Transm 109 (2002) 921-929
167. Suvisaari J., Haukka J., Tanskanen A., Hovi T., and Lonnqvist J. Association between prenatal exposure to poliovirus infection and adult schizophrenia. Am J Psychiatry 156 (1999) 1100-1102
168. Swerdlow N.R., Geyer M.A., and Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156 (2001) 194-215
169. Swerdlow N.R., and Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24 (1998) 285-301
170. Taepavarapruk P., Floresco S.B., and Phillips A.G. Hyperlocomotion and increased dopamine efflux in the rat nucleus accumbens evoked by electrical stimulation of the ventral subiculum: role of ionotropic glutamate and dopamine D1 receptors. Psychopharmacology 151 (2000) 242-251
171. Tamminga C.A. The neurobiology of cognition in schizophrenia. J Clin Psychiatry 67 Suppl. 9 (2006) 9-13
172. Tang Y.P., Shimizu E., Dube G.R., Rampon C., Kerchner G.A., Zhuo M., et al. Genetic enhancement of learning and memory in mice. Nature 401 (1999) 63-69
173. Torrey E.F., Rawlings R., and Waldman I.N. Schizophrenic births and viral diseases in two states. Schizophr Res 1 (1988) 73-77
174. Toru M., Nishikawa T., Mataga N., and Takashima M. Dopamine metabolism increases in post-mortem schizophrenic basal ganglia. J Neural Transm 54 (1982) 181-191
175. Toru M., Watanabe S., Shibuya H., Nishikawa T., Noda K., Mitsushio H., et al. Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. Acta Psychiatr Scand 78 (1988) 121-137
176. Totterdell S., and Meredith G.E. Topographical organization of projections from the entorhinal cortex to the striatum of the rat. Neuroscience 78 (1997) 715-729
177. Totterdell S., and Smith A.D. Convergence of hippocampal and dopaminergic input onto identified neurons in the nucleus accumbens of the rat. J Chem Neuroanat 2 (1989) 285-298
178. Tsai G., and Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol 42 (2002) 165-179
179. Vezina P., Blanc G., Glowinski J., and Tassin J.P. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse 16 (1994) 104-112
180. Vezina P., Blanc G., Glowinski J., and Tassin J.P. Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: a role for the cortical D-1 dopaminer. Eur J Neurosci 3 (1991) 1001-1007
181. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., and Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry 57 (2000) 237-245
182. Volk D.W., and Lewis D.A. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav 77 (2002) 501-505
183. Volk D.W., Pierri J.N., Fritschy J.M., Auh S., Sampson A.R., and Lewis D.A. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 12 (2002) 1063-1070
184. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44 (1987) 660-669
185. Weiner I., Gal G., Rawlins J.N., and Feldon J. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity. Behav Brain Res 81 (1996) 123-133
186. Weiner I. "The two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169 (2003) 257-297
187. Whitley R.J., and Stagno S. Perinatal infections. In: Scheld W.M., Whitley R.J., and Durack D.T. (Eds). Infections of the central nervous system. 2nd ed. (1997), Lippincott-Raven Press, New York 223-253
188. Winter C, Djodari-Irani A, Sohr R, Morgenstern R, Feldon J, Juckel G, et al. Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: Implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int J Neuropsychopharmacol; in press (Epub ahead of print [PMID: 18752727]).
189. Winter C., Reutiman T.J., Folsom T.D., Sohr R., Wolf R.J., Juckel G., and Fatemi S.H. Dopamine and serotonin levels following prenatal viral infection in mouse-implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol 18 (2008) 712-716
190. Winterer G., and Weinberger D.R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 27 (2004) 683-690
191. Wolff A.R., and Bilkey D.K. Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring. Behav Brain Res 190 (2008) 156-159
192. Woo T.U., Miller J.L., and Lewis D.A. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry 154 (1997) 1013-1015
193. Woo T.U., Whitehead R.E., Melchitzky D.S., and Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 95 (1998) 5341-5346
194. Yan Q.S., Reith M.E., Jobe P.C., Dailey J.W., and Dizocilpine. (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res 765 (1997) 149-158
195. Zhang W.N., Bast T., and Feldon J. Effects of hippocampal N-methyl-d-aspartate infusion on locomotor activity and prepulse inhibition: differences between the dorsal and ventral hippocampus. Behav Neurosci 116 (2002) 72-84
196. Zhang W.N., Pothuizen H.H., Feldon J., and Rawlins J.N. Dissociation of function within the hippocampus: effects of dorsal, ventral and complete excitotoxic hippocampal lesions on spatial navigation. Neuroscience 127 (2004) 289-300
197. Zornoza T., Cano-Cebrián M.J., Miquel M., Aragón C., Polache A., and Granero L. Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus. Neuropsychopharmacology 30 (2005) 843-852
198. Zuckerman L., Rehavi M., Nachman R., and Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28 (2003) 1778-1789
199. Zuckerman L., and Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 39 (2005) 311-323
200. Zuckerman L., and Weiner I. Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation. Psychopharmacology 169 (2003) 308-313